Retifanlimab In Patients With Recurrent Microsatellite Instability-High (Msi-H) Or Deficient Mismatch Repair (Dmmr) Endometrial Cancer: Final Results From The Pod1Um-101 Study (Cohort H)
Retifanlimab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Retifanlimab In Patients With Recurrent Microsatellite Instability-High (Msi-H) Or Deficient Mismatch Repair (Dmmr) Endometrial Cancer: Final Results From The Pod1Um-101 Study (Cohort H) ### Output: Retifanlimab